Longitudinal neuroimaging biomarkers differ across Alzheimer's disease phenotypes.
暂无分享,去创建一个
Peter R. Martin | David T. Jones | C. Jack | R. Petersen | J. Graff‐Radford | B. Boeve | M. Senjem | D. Knopman | V. Lowe | K. Kantarci | C. Schwarz | J. Whitwell | K. Josephs | M. Machulda | Peter R Martin | Irene Sintini
[1] W. M. van der Flier,et al. Test–retest repeatability of [18F]Flortaucipir PET in Alzheimer’s disease and cognitively normal individuals , 2019, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[2] Nick C Fox,et al. Longitudinal neuroanatomical and cognitive progression of posterior cortical atrophy , 2019, Brain : a journal of neurology.
[3] Peter R. Martin,et al. The role of age on tau PET uptake and gray matter atrophy in atypical Alzheimer's disease , 2019, Alzheimer's & Dementia.
[4] Stephen Salloway,et al. A multicentre longitudinal study of flortaucipir (18F) in normal ageing, mild cognitive impairment and Alzheimer’s disease dementia , 2019, Brain : a journal of neurology.
[5] J. Gee,et al. Longitudinal progression of grey matter atrophy in non-amnestic Alzheimer's disease. , 2019, Brain : a journal of neurology.
[6] Peter R. Martin,et al. Longitudinal tau-PET uptake and atrophy in atypical Alzheimer's disease , 2019, NeuroImage: Clinical.
[7] M. Mesulam,et al. Clinical and cortical decline in the aphasic variant of Alzheimer's disease , 2019, Alzheimer's & Dementia.
[8] Theresa M. Harrison,et al. Longitudinal tau accumulation and atrophy in aging and alzheimer disease , 2019, Annals of neurology.
[9] Christopher G Schwarz,et al. Regional multimodal relationships between tau, hypometabolism, atrophy, and fractional anisotropy in atypical Alzheimer's disease , 2018, Human brain mapping.
[10] Alan C. Evans,et al. Data‐driven approaches for tau‐PET imaging biomarkers in Alzheimer's disease , 2018, Human brain mapping.
[11] K. Blennow,et al. Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer’s disease , 2019, European Journal of Nuclear Medicine and Molecular Imaging.
[12] B. Miller,et al. Discriminative Accuracy of [18F]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative Disorders , 2018, JAMA.
[13] Clifford R. Jack,et al. Imaging correlations of tau, amyloid, metabolism, and atrophy in typical and atypical Alzheimer's disease , 2018, Alzheimer's & Dementia.
[14] Christopher G Schwarz,et al. Longitudinal tau PET in ageing and Alzheimer’s disease , 2018, Brain : a journal of neurology.
[15] Peter R. Martin,et al. [18F]AV‐1451 tau‐PET and primary progressive aphasia , 2018, Annals of neurology.
[16] J. Trojanowski,et al. Neocortical origin and progression of gray matter atrophy in nonamnestic Alzheimer's disease , 2018, Neurobiology of Aging.
[17] David T. Jones,et al. [18F]AV‐1451 clustering of entorhinal and cortical uptake in Alzheimer's disease , 2018, Annals of neurology.
[18] Peter R. Martin,et al. Regional Distribution, Asymmetry, and Clinical Correlates of Tau Uptake on [18F]AV-1451 PET in Atypical Alzheimer's Disease. , 2018, Journal of Alzheimer's disease : JAD.
[19] Christopher G Schwarz,et al. Widespread brain tau and its association with ageing, Braak stage and Alzheimer's dementia. , 2018, Brain : a journal of neurology.
[20] O Almkvist,et al. Longitudinal changes of tau PET imaging in relation to hypometabolism in prodromal and Alzheimer’s disease dementia , 2018, Molecular Psychiatry.
[21] Clifford R. Jack,et al. Tau, amyloid, and cascading network failure across the Alzheimer's disease spectrum , 2017, Cortex.
[22] C. Jack,et al. Rates of hippocampal atrophy and post-mortem TDP-43 in Alzheimer’s disease: a longitudinal retrospective study , 2017, The Lancet Neurology.
[23] Rik Ossenkoppele,et al. Distinct 18F‐AV‐1451 tau PET retention patterns in early‐ and late‐onset Alzheimer's disease , 2017, Brain : a journal of neurology.
[24] C. Jack,et al. THE MAYO CLINIC ADULT LIFE SPAN TEMPLATE: BETTER QUANTIFICATION ACROSS THE LIFE SPAN , 2017, Alzheimer's & Dementia.
[25] Keith A. Johnson,et al. Association of In Vivo [18F]AV-1451 Tau PET Imaging Results With Cortical Atrophy and Symptoms in Typical and Atypical Alzheimer Disease , 2017, JAMA neurology.
[26] David T. Jones,et al. Defining imaging biomarker cut points for brain aging and Alzheimer's disease , 2017, Alzheimer's & Dementia.
[27] Gereon R Fink,et al. In vivo Patterns of Tau Pathology, Amyloid-β Burden, and Neuronal Dysfunction in Clinical Variants of Alzheimer's Disease. , 2016, Journal of Alzheimer's disease : JAD.
[28] Daniel R. Schonhaut,et al. Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease. , 2016, Brain : a journal of neurology.
[29] Frederik Barkhof,et al. Atrophy patterns in early clinical stages across distinct phenotypes of Alzheimer's disease , 2015, Human brain mapping.
[30] Clifford R. Jack,et al. Accelerated vs. unaccelerated serial MRI based TBM-SyN measurements for clinical trials in Alzheimer's disease , 2015, NeuroImage.
[31] B. Miller,et al. Longitudinal gray matter contraction in three variants of primary progressive aphasia: A tenser-based morphometry study , 2015, NeuroImage: Clinical.
[32] Sandra Weintraub,et al. Primary progressive aphasia and the evolving neurology of the language network , 2014, Nature Reviews Neurology.
[33] C. Jack,et al. TDP-43 is a key player in the clinical features associated with Alzheimer’s disease , 2014, Acta Neuropathologica.
[34] Nick C. Fox,et al. Patterns of longitudinal brain atrophy in the logopenic variant of primary progressive aphasia , 2013, Brain and Language.
[35] Yong He,et al. BrainNet Viewer: A Network Visualization Tool for Human Brain Connectomics , 2013, PloS one.
[36] C. Jack,et al. Thrombogenic microvesicles and white matter hyperintensities in postmenopausal women , 2013, Neurology.
[37] Cindee M. Madison,et al. Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer's disease. , 2013, Brain : a journal of neurology.
[38] Nick C. Fox,et al. Global gray matter changes in posterior cortical atrophy: A serial imaging study , 2012, Alzheimer's & Dementia.
[39] Nick C Fox,et al. Posterior cortical atrophy , 2012, The Lancet Neurology.
[40] R. Petersen,et al. Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study , 2011, The Lancet Neurology.
[41] C. Jack,et al. Temporoparietal atrophy: A marker of AD pathology independent of clinical diagnosis , 2011, Neurobiology of Aging.
[42] T. Gollan,et al. Self-ratings of spoken language dominance: A Multilingual Naming Test (MINT) and preliminary norms for young and aging Spanish–English bilinguals* , 2011, Bilingualism: Language and Cognition.
[43] J. Morris,et al. The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.
[44] M. Mesulam,et al. ApoE E4 is a Susceptibility Factor in Amnestic But Not Aphasic Dementias , 2011, Alzheimer disease and associated disorders.
[45] Nick C Fox,et al. Early-onset versus late-onset Alzheimer's disease: the case of the missing APOE ɛ4 allele , 2011, The Lancet Neurology.
[46] B. Miller,et al. Classification of primary progressive aphasia and its variants , 2011, Neurology.
[47] D. Selkoe. Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.
[48] Nick C. Fox,et al. Patterns of Cortical Thickness according to APOE Genotype in Alzheimer’s Disease , 2009, Dementia and Geriatric Cognitive Disorders.
[49] Guido Rodriguez,et al. Principal component analysis in mild and moderate Alzheimer's disease — A novel approach to clinical diagnosis , 2009, Psychiatry Research: Neuroimaging.
[50] Norbert Schuff,et al. Alzheimer’s Disease Neuroimaging Initiative: A one-year follow up study using Tensor-Based Morphometry correlating degenerative rates, biomarkers and cognition , 2009 .
[51] C. Jack,et al. 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment. , 2008, Brain : a journal of neurology.
[52] V. Pankratz,et al. The Mayo Clinic Study of Aging: Design and Sampling, Participation, Baseline Measures and Sample Characteristics , 2008, Neuroepidemiology.
[53] Brian B. Avants,et al. Symmetric diffeomorphic image registration with cross-correlation: Evaluating automated labeling of elderly and neurodegenerative brain , 2008, Medical Image Anal..
[54] C. Jack,et al. 11 C PiB and structural MRI provide complementary information in imaging of Alzheimer ’ s disease and amnestic mild cognitive impairment , 2008 .
[55] C. Jack,et al. Imaging correlates of posterior cortical atrophy , 2007, Neurobiology of Aging.
[56] C. Jack,et al. 3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease. , 2007, Brain : a journal of neurology.
[57] E. Tangalos,et al. Mayo's Older Americans Normative Studies: Visual Form Discrimination and copy trial of the Rey–Osterrieth Complex Figure , 2007, Journal of clinical and experimental neuropsychology.
[58] Clifford R. Jack,et al. 3 D maps frommultiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer ’ s disease , 2007 .
[59] Karl J. Friston,et al. Unified segmentation , 2005, NeuroImage.
[60] J. Cummings,et al. The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment , 2005, Journal of the American Geriatrics Society.
[61] G. Frisoni,et al. Structural correlates of early and late onset Alzheimer’s disease: voxel based morphometric study , 2004, Journal of Neurology, Neurosurgery & Psychiatry.
[62] H. Braak,et al. Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.
[63] J. Baron,et al. Efficient principal component analysis for multivariate 3D voxel‐based mapping of brain functional imaging data sets as applied to FDG‐PET and normal aging , 2003, Human brain mapping.
[64] Nick C Fox,et al. Mapping the evolution of regional atrophy in Alzheimer's disease: Unbiased analysis of fluid-registered serial MRI , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[65] A. Loonstra,et al. COWAT Metanorms Across Age, Education, and Gender , 2001, Applied neuropsychology.
[66] K Patterson,et al. Atypical and typical presentations of Alzheimer's disease: a clinical, neuropsychological, neuroimaging and pathological study of 13 cases. , 2000, Brain : a journal of neurology.
[67] R. Ivnik,et al. An empirically derived short form of the Boston naming test. , 1999, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.
[68] M. Mesulam,et al. Apolipoprotein E genotypes in primary progressive aphasia , 1997, Neurology.
[69] James F. Malec,et al. Mayo's older americans normative studies: Updated AVLT norms for ages 56 to 97 , 1992 .
[70] I. Jolliffe. Principal Component Analysis , 2005 .
[71] C. P. Hughes,et al. A New Clinical Scale for the Staging of Dementia , 1982, British Journal of Psychiatry.